Rabeprazole Itopride Pellets Manufacturer & Supplier
Combination pellets aligning acid suppression with prokinetic support for gastrointestinal symptom management.
Product overview
Rabeprazole provides proton pump inhibition while Itopride supports gastrointestinal motility. The system is built around controlled pellet characteristics to support reliable capsule filling and formulation scale-up.
Key characteristics
- Dual-action combination pellets.
- Controlled release support for both actives.
- Suitable for capsule and multiparticulate development.
- Support for formulation optimization and technical documentation.
Product specifications
- Product
- Rabeprazole Itopride Pellets
- Form
- Pellets
- Therapeutic category
- Anti-Ulcerant (PPIs)
- Strength
- 20 mg + 50 mg
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Rabeprazole Itopride Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Rabeprazole products from Rraynex
- Rabeprazole (API) — API
- Rabeprazole + Domperidone — Granules
- Rabeprazole DC — Granules
- 2-((((4-(3-methoxypropoxy)-3-methylpyridine-2-yl)methyl)thio)-1H-benzo[d]imidazole — Intermediate
- 2-(Chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine HCl — Intermediate
- Rabeprazole + Domperidone — Pellets
- Rabeprazole + Levosulpiride — Pellets
- Rabeprazole EC — Pellets
- Rabeprazole MUPS — Pellets
- Rabeprazole Sodium EC — Pellets
- Rabeprazole Sodium EC + Aceclofenac SR — Pellets